Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches
- PMID: 39805949
- DOI: 10.1038/s41569-024-01115-w
Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches
Abstract
Atherosclerosis is a disease of large and medium arteries that can lead to life-threatening cardiovascular and cerebrovascular consequences, such as myocardial infarction and stroke. Moreover, atherosclerosis is a major contributor to cardiovascular-related mortality in individuals with diabetes mellitus. Diabetes aggravates the pathobiological mechanisms that underlie the development of atherosclerosis. Currently available anti-atherosclerotic drugs or strategies solely focus on optimal control of systemic risk factors, including hyperglycaemia and dyslipidaemia, but do not adequately target the diabetes-exacerbated mechanisms of atherosclerotic cardiovascular disease, highlighting the need for targeted, mechanism-based therapies. This Review focuses on emerging pathological mechanisms and related novel therapeutic targets in atherosclerotic cardiovascular disease in patients with diabetes.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
References
-
- Low Wang, C. C., Hess, C. N., Hiatt, W. R. & Goldfine, A. B. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus – mechanisms, management, and clinical considerations. Circulation 133, 2459–2502 (2016). - PubMed - PMC - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
